focus_keyword

Societe Generale buys 0.7 stake in Strides Pharma, Mayfield XII

News

focus_keywordfocus_keyword

France-headquartered Societe Generale acquired 0.7 % fairness stake in Strides Pharma Science through open market transaction on September 8.

Societe Generale purchased 6,26,279 shares within the pharma firm at Rs 612 per share, the majority offers information accessible on the Nationwide Inventory Trade (NSE) confirmed.

Nonetheless, Brookdale Mauritius Worldwide was the vendor, which offloaded 6,26,279 shares within the firm at Rs 612 per share.

Brookdale Mauritius held 13,91,404 fairness shares, or 1.55 %, stake in Strides as of June 2020.

Amongst different offers, Mayfield XII Mauritius FDI bought 44,42,733 shares in Tejas Networks (representing 4.Eight % of complete paid up fairness) at Rs 66.46 per share.

Mayfield XII Mauritius held 71,06,628 fairness shares (representing 7.7 % of complete paid up fairness) as of June 2020.

Enam Finance bought 1 crore fairness shares in Future Shopper at Rs 10.13 per share.

Edelweiss Crossover Alternatives Fund offloaded 4,21,609 fairness shares in Future Provide Chain Options at Rs 129.33 per share and Dhunseri Ventures bought 2,27,744 shares at Rs 129.2 per share.

Tejas Tradefin LLP internet purchased over three lakh shares in Future Provide at Rs 129.2 per share.

First Revealed on Sep 8, 2020 10:57 pm

Source

Leave a Reply

Your email address will not be published. Required fields are marked *